Relapsed

Related by string. relapsed * * relapsing remitting multiple sclerosis . relapsed refractory multiple myeloma . relapsed ovarian cancer . relapsed multiple myeloma . relapsing remitting . Relapsing Remitting Multiple Sclerosis . relapsing remitting MS RRMS . relapsing remitting MS . relapsed refractory AML . Relapsing Remitting MS RRMS . relapsed refractory *

Related by context. Frequent words. (Click for all words.) 73 Elderly Patients 73 Chronic Hepatitis C 73 Patients Treated 73 Monotherapy 69 Phase III Trial 68 Postmenopausal Women 67 Bortezomib 67 Clinical Trial Results 67 Solid Tumors 66 Voreloxin 66 Completes Enrollment 66 Tolerability 66 Lenalidomide 66 Drug Candidate 66 Chronic Lymphocytic Leukemia 66 Increased Risk 65 Induces 65 Combination Therapy 65 FOLFIRI 65 Heart Failure Patients 64 Inhibits 64 Carcinoma 64 Initiates Phase 64 Breast Cancer Patients 64 Irinotecan 63 Trastuzumab 63 Randomized Controlled Trial 63 Bevacizumab 63 Phase III Clinical Trial 63 Meta Analysis 63 Metastatic Breast Cancer 63 REVLIMID R 63 unresectable 63 Pivotal Phase 62 Gemcitabine 62 DOXIL 62 Rituximab 62 Low Dose 62 relapsed refractory 62 Dexamethasone 62 Pivotal Phase III 62 Pivotal Trial 62 Subcutaneous 62 Metastatic 62 Study Demonstrates 62 dacarbazine 61 Asymptomatic 61 Enoxaparin 61 Ofatumumab 61 Blood Clots 61 metastatic renal cell carcinoma 61 Shows Promise 61 J Am Acad 61 Cell Lung Cancer 61 Increases Risk 61 Infliximab 61 Acute Myeloid Leukemia AML 61 tumor lysis syndrome 60 relapsed refractory multiple myeloma 60 refractory peripheral T 60 plus prednisone 60 vinorelbine 60 relapsed multiple myeloma 60 Lymphomas 60 Erlotinib 60 Acute Myocardial Infarction 60 Cisplatin 60 plus dexamethasone 59 Insulin Resistance 59 lymphoma CTCL 59 Prophylaxis 59 imatinib mesylate 59 REVLIMID ® 59 Bladder Cancer 59 Monoclonal Antibody 59 Breast Cancer Treatment 59 cutaneous T cell 59 Liver Cancer 59 Taxotere ® 59 fluorouracil 58 Carboplatin 58 refractory multiple myeloma 58 FDA Approves 58 HER2 positive metastatic breast 58 Acute Myeloid Leukemia 58 Amrubicin 58 HGS ETR1 58 nab paclitaxel 58 mg BID 58 azacitidine 58 fludarabine 58 Ischemic 58 Docetaxel 58 FOLFOX 58 Navelbine 58 Ribavirin 58 Pharmacokinetics 58 plus gemcitabine 57 xenograft models 57 Alemtuzumab 57 Imatinib

Back to home page